Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000886163-11-000059)

Filing Details

Accession Number:: 0000886163-11-000059
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2011-08-11 20:08:11
Reporting Period:: 2011-08-10

Filing Date:: 2011-08-11
Accepted Time:: 2011-08-11 20:08:11
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
886163	Ligand Pharmaceuticals Inc	LGND	Pharmaceutical Preparations (2834)	770160744

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1392029	C Todd Davis	11085 North Torrey Pines Road, Suite 300 La Jolla CA 92037		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-08-10	15,000	$10.90	29,201	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $10.668 - $11.239. Upon request, Ligand Pharmaceuticals Incorporated will provide full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) of this Form 4.